Advertisement

Charles River Laboratories International Inc. (NYSE: CRL) moved around business units, unifying its Research Models and Services (RMS) and Preclinical Services (PCS) businesses, the company announced in a release late yesterday

According to James C. Foster, chairman, president and CEO of Wilimngton-based Charles River Labs, the unified business will now primarily be managed in two regions: North America and Europe/Asia. The following scientists and business leaders will be responsible for linking the businesses and maintaining scientific oversight. The company said in the release that it did not expect that its financial segment reporting would change as a result of the re-alignment.

SOURCE

Advertisement
Advertisement